2013 Fiscal Year Final Research Report
Investigation of the pathogenesis of pulmonary arterial hypertension focusing on BMP signaling in pulmonary arterial smooth muscle cells.
Project/Area Number |
24790759
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Circulatory organs internal medicine
|
Research Institution | Okayama University |
Principal Investigator |
TAKEDA Masaya 岡山大学, 医学部, 客員研究員 (80534685)
|
Project Period (FY) |
2012-04-01 – 2014-03-31
|
Keywords | 原発性肺高血圧症 / 二次性肺高血圧症 / 骨形成蛋白 / PPARγ |
Research Abstract |
The pathogenesis of primary arterial hypertension (PAH) was investigated by focusing on bone morphogenetic protein (BMP) and PPARs in pulmonary artery smooth muscle cells (PASMC). The expression of PPAR-gamma was decreased in PASMC from secondary pulmonary hypertension (SPH) compared with that from PAH. PAH cell proliferation induced by PDGF, ET-1 and BMP was suppressed by PPAR-gamma activation. The reduction of PPAR-gamma expression was related to proliferation of PASMC in response to various vasoactive agents. The expression of BMP receptors was suppressed by the activation of PPAR-gamma in both PAH- and SPH-PASMCs, suggesting the existence of a feedback system of BMP-PPAR in PASMCs. Thus, PPAR-gamma in PASMCs is likely to be involved in the suppression of PASMC proliferation in different ways between PAH and SPH.
|
Research Products
(4 results)